サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1758037

生体インプラントの世界市場

Biological Implants

出版日
ページ情報
英文 281 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
生体インプラントの世界市場
出版日: 2025年06月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 281 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生体インプラントの世界市場は2030年までに110億米ドルに達する見込み

2024年に86億米ドルと推定される生体インプラントの世界市場は、分析期間2024-2030年にCAGR 4.2%で成長し、2030年には110億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである生物学的自己移植片は、CAGR 3.7%を記録し、分析期間終了時には63億米ドルに達すると予想されます。生物学的同種移植片セグメントの成長率は、分析期間中CAGR 4.8%と推定されます。

米国市場は23億米ドルと推定、中国はCAGR6.6％で成長予測

米国の生体インプラント市場は、2024年に23億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに21億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.0％と4.3％と予測されています。欧州では、ドイツがCAGR 2.7%で成長すると予測されています。

世界の生体インプラント市場- 主要動向と促進要因のまとめ

なぜ生体インプラントが再生医療と外科手術の未来を形作るのか？

生体インプラントは、様々な臨床応用において、自然治癒、組織統合、機能回復を促進する生物学的に適合したソリューションを提供することで、現代医療に革命を起こしています。生体インプラントは、金属やプラスチックから作られた合成インプラントとは異なり、ヒト（自家移植片または同種移植片）または動物（異種移植片）の天然組織から作られ、重要な生物学的構造を保持しながら、生体適合性と無菌性を確保するように加工されています。これらのインプラントは、細胞増殖を促進し、免疫拒絶反応を抑え、治癒成績を向上させる能力があるため、整形外科、心臓血管外科、歯科、眼科、再建外科などでますます使用されるようになっています。また、加齢に伴う退行性疾患や外傷、関節置換術や臓器再建術などの外科的処置が世界的に増加していることも、その普及を後押ししています。例えば整形外科手術では、生物学的足場や移植片が、損傷した靭帯、腱、軟骨の代わりや補強となり、より自然な回復経路と合併症の減少を実現しています。同様に、心臓血管外科手術では、血栓発生リスクが低く、生涯にわたる抗凝固療法の必要性が少ないことから、機械的な代替品よりも生物学的心臓弁が支持されています。生物学的インプラントに対する需要は、低侵襲手術、回復時間の短縮、長期的な異物反応の発生率の低さといった患者の嗜好によってさらに高まっています。ヘルスケアが再生医療や個別化医療へとシフトする中、生体インプラントは外科技術革新の最前線に立ち、臨床医が治癒や構造修復にアプローチする方法を変革しています。

技術革新は生体インプラントの性能と信頼性をどのように高めていますか？

生体インプラントの性能と信頼性は、組織工学、材料科学、バイオメディカル技術の継続的な進歩により著しく向上しています。脱細胞化技術はより精密になり、宿主組織の統合をサポートする細胞外マトリックスを保持したまま、ドナーの細胞内容を除去することができるようになりました。この技術革新は、耐荷重や構造的応用に必要な機械的完全性を維持しながら、免疫原性を大幅に減少させる。さらに、ガンマ線照射、超臨界CO2、エチレンオキシドを用いた滅菌法は、組織の特性を劣化させることなく安全性を確保するために改良されています。3Dバイオプリンティングを含むバイオファブリケーション技術により、患者の解剖学的構造や治癒要件に合わせた細胞や成長因子を埋め込んだ、カスタマイズされた移植可能な足場の作成が可能になりました。ナノテクノロジーもこの進歩に貢献しており、ナノ構造のコーティングやドラッグデリバリーシステムが生体インプラントに組み込まれ、抗生物質や抗炎症剤、再生化合物を経時的に放出するようになっています。さらに研究者は、天然組織と生体吸収性ポリマーを組み合わせ、構造強度を高め、分解速度を調整する複合生体インプラントを開発しています。MRIやCTのような画像技術の向上により、術前計画が容易になり、インプラントと宿主組織とのマッチングが改善され、手術成績が向上し、術後合併症が減少しています。デジタルヘルスツールやウェアラブルがインプラントと組み合わされ、統合や治癒をリアルタイムでモニターするようになり、スマートインプラントシステムの幕開けとなりつつあります。これらの技術的進歩は、生体インプラントの品質と安全性を向上させるだけでなく、複雑な医療課題への適用範囲を広げています。

生物学的インプラントの採用が急増している医療分野と世界地域は？

生体インプラントの採用は、組織修復と生体適合性が最も重要な複数の医療分野で急増しています。整形外科は依然として支配的な分野であり、半月板移植片、骨移植片、腱足場などのインプラントがスポーツ外傷、骨折、変性疾患の修復に使用されています。心臓血管医療も主要な牽引役であり、特に弁の修復や先天性欠損の修正に生体人工心臓弁、血管パッチ、心膜組織が使用されています。再建外科や形成外科では、外傷、火傷、美容整形後の組織再生をサポートするために、真皮マトリックスやコラーゲン・スキャフォールドに大きく依存しています。歯科外科では、歯周病の修復やインプラントの固定に生体膜や骨代替物が使用されています。眼科や神経外科でも、拒絶反応のリスクを最小限に抑えながら硬膜や眼球組織を修復するために、生物学的材料を組み込んでいます。地域別では、北米が高いヘルスケア支出、先進的な手術インフラ、有利な償還制度により世界市場をリードしています。特に米国は、強固な移植ネットワークと、安全性と技術革新を保証する強力な規制枠組の恩恵を受けています。欧州は、再生医療に対する政府の支援と大手バイオテクノロジー企業の存在によって、僅差で続いています。アジア太平洋は、医療投資の増加、認知度の向上、中国、インド、日本のような国々における大規模な患者基盤に後押しされて、最も急速に成長している市場です。ラテンアメリカと中東は、医療アクセスの改善と医療ツーリズムの台頭が需要を押し上げている新興地域です。このように様々な地域で、患者中心で組織適合性の高いソリューションへの注目が高まっているため、生体インプラントは従来の合成品よりも好ましい選択肢となっています。

生体インプラントの世界市場成長の原動力は？

生体インプラントの世界市場の成長は、医療、技術、人口統計、政策など多面的な要因によって牽引されています。その最たるものが、変形性関節症、心血管障害、糖尿病などの慢性疾患による世界の負担の増大であり、インプラントを用いた外科的介入が頻繁に必要となります。特に先進国や中所得国では高齢化が進んでおり、高齢患者は人工関節置換術、弁膜症手術、組織再建術を受ける可能性が高いため、これも需要の増加に寄与しています。さらに、低侵襲治療や再生治療の動向は、外科的外傷や回復時間を軽減しながら自然治癒を促進する生物学的に適合性の高いインプラントを選択するよう臨床医を後押ししています。バイオエンジニアリング、3Dバイオプリンティング、細胞治療などの技術革新は、移植可能な生物学的材料の範囲と有効性を拡大しています。FDAやEMAなどの規制機関は、未充足の臨床ニーズに対応できる可能性を認識し、生物学的製剤の承認経路を合理化しています。保険適用や償還のモデルも、特に臨床的証拠によって長期的な安全性と有効性が検証され続けていることから、こうした新しいソリューションに対応できるように進化しています。さらに、学術機関、バイオテクノロジー新興企業、および既存の医療技術企業間の協力関係の強化により、研究、商業化、および世界の流通が加速しています。合成インプラントをめぐる環境問題や倫理的懸念も、生分解性や生物学的由来の代替品へのシフトを促しています。これらの要因が相まって、生体インプラントは次世代医療の重要な要素として位置づけられ、機能の回復が置換のみによって達成されるのではなく、真の生物学的統合と再生によって達成されるようになっています。

セグメント

製品（生物学的自家移植片、生物学的同種移植片、生物学的異種移植片）;用途（心臓血管インプラント用途、整形外科インプラント用途、その他の用途）

調査対象企業の例（注目の44社）

  • Abbott Laboratories
  • AbbVie Inc.
  • Aroa Biosurgery
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical Inc.
  • Dentsply Sirona Inc.
  • Edwards Lifesciences Corporation
  • Globus Medical Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson（DePuy Synthes）
  • LivaNova PLC
  • Mathys Ltd Bettlach
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive Inc.
  • Smith & Nephew plc
  • Stryker Corporation

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36381

Global Biological Implants Market to Reach US$11.0 Billion by 2030

The global market for Biological Implants estimated at US$8.6 Billion in the year 2024, is expected to reach US$11.0 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Biological Autografts, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.3 Billion by the end of the analysis period. Growth in the Biological Allografts segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 6.6% CAGR

The Biological Implants market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Biological Implants Market - Key Trends & Drivers Summarized

Why Are Biological Implants Reshaping the Future of Regenerative Medicine and Surgical Interventions?

Biological implants are revolutionizing modern medicine by providing biologically compatible solutions that facilitate natural healing, tissue integration, and functional restoration in a variety of clinical applications. Unlike synthetic implants made from metals or plastics, biological implants are derived from natural tissues-either human (autografts or allografts) or animal (xenografts)-that are processed to ensure biocompatibility and sterility while retaining essential biological structures. These implants are increasingly used in orthopedic, cardiovascular, dental, ophthalmic, and reconstructive surgeries due to their ability to promote cellular growth, reduce immune rejection, and improve healing outcomes. Their widespread adoption is also being driven by the global increase in age-related degenerative diseases, trauma-related injuries, and surgical interventions such as joint replacements and organ reconstructions. For example, in orthopedic procedures, biological scaffolds and grafts are replacing or augmenting damaged ligaments, tendons, and cartilage with more natural recovery paths and fewer complications. Similarly, in cardiovascular surgery, biological heart valves are favored over mechanical alternatives for their lower thrombogenic risk and reduced need for lifelong anticoagulation therapy. The demand for biologically derived implants is further amplified by patient preference for minimally invasive procedures, faster recovery times, and lower incidences of long-term foreign body reactions. As healthcare shifts towards regenerative and personalized medicine, biological implants stand at the forefront of surgical innovation-transforming the way clinicians approach healing and structural repair.

How Are Technological Innovations Enhancing the Performance and Reliability of Biological Implants?

The performance and reliability of biological implants have been significantly improved by ongoing advancements in tissue engineering, material science, and biomedical technologies. Decellularization techniques have become more precise, allowing the removal of donor cellular content while preserving the extracellular matrix that supports host tissue integration. This innovation greatly reduces immunogenicity while maintaining the mechanical integrity necessary for load-bearing or structural applications. Furthermore, sterilization methods using gamma irradiation, supercritical CO2, and ethylene oxide are now refined to ensure safety without degrading tissue properties. Biofabrication technologies, including 3D bioprinting, have enabled the creation of customized implantable scaffolds embedded with cells and growth factors tailored to the patient’s anatomy and healing requirements. Nanotechnology is also contributing to this progress, with nanostructured coatings and drug delivery systems being integrated into biological implants to release antibiotics, anti-inflammatory agents, or regenerative compounds over time. Additionally, researchers are developing composite biological implants that combine natural tissues with bioresorbable polymers to enhance structural strength and tailor degradation rates. Improvements in imaging technologies like MRI and CT have facilitated preoperative planning and better matching of implants with host tissue, improving surgical outcomes and reducing postoperative complications. Digital health tools and wearables are starting to be paired with implants to monitor integration and healing in real time, marking the beginning of smart implant systems. Together, these technological advancements are not only improving the quality and safety of biological implants but are also broadening their applicability across complex medical challenges.

Which Medical Fields and Global Regions Are Leading the Surge in Biological Implant Adoption?

The adoption of biological implants is surging across multiple medical fields where tissue restoration and biocompatibility are paramount. Orthopedics remains a dominant sector, where implants like meniscal allografts, bone grafts, and tendon scaffolds are used to repair sports injuries, fractures, and degenerative conditions. Cardiovascular medicine is another major driver, particularly in the use of bioprosthetic heart valves, vascular patches, and pericardial tissues for valve repair and congenital defect correction. Reconstructive and plastic surgery heavily relies on dermal matrices and collagen scaffolds to support tissue regeneration following trauma, burns, or cosmetic enhancements. In dental surgery, biological membranes and bone substitutes are used for periodontal repairs and implant anchoring. Ophthalmology and neurosurgery are also integrating biologically based materials to repair dura mater or ocular tissues with minimal rejection risk. Regionally, North America leads the global market due to high healthcare expenditure, advanced surgical infrastructure, and favorable reimbursement systems. The United States, in particular, benefits from a robust transplant network and strong regulatory frameworks that ensure safety and innovation. Europe follows closely, driven by government support for regenerative medicine and the presence of leading biotech firms. Asia-Pacific is the fastest-growing market, fueled by rising healthcare investments, increasing awareness, and a large patient base in countries like China, India, and Japan. Latin America and the Middle East are emerging regions where improvements in healthcare access and the rise of medical tourism are boosting demand. Across these varied geographies, the increasing focus on patient-centric, tissue-compatible solutions is making biological implants a preferred choice over traditional synthetic options.

What Is Fueling the Growth in the Global Biological Implants Market?

The growth in the global biological implants market is driven by a multifaceted combination of medical, technological, demographic, and policy-related factors that are collectively reshaping surgical care. Foremost among these is the rising global burden of chronic diseases, such as osteoarthritis, cardiovascular disorders, and diabetes, which frequently necessitate implant-based surgical interventions. The growing aging population, particularly in developed and middle-income countries, also contributes to increased demand, as elderly patients are more likely to undergo joint replacements, valve surgeries, and tissue reconstruction procedures. Moreover, the trend toward minimally invasive and regenerative treatments is pushing clinicians to choose biologically compatible implants that promote natural healing while reducing surgical trauma and recovery times. Technological innovation, including advancements in bioengineering, 3D bioprinting, and cellular therapies, is expanding the range and effectiveness of implantable biological materials. Regulatory bodies such as the FDA and EMA are streamlining approval pathways for biologics, recognizing their potential to address unmet clinical needs. Insurance coverage and reimbursement models are also evolving to accommodate these newer solutions, particularly as clinical evidence continues to validate their long-term safety and efficacy. Furthermore, increasing collaboration between academic institutions, biotech startups, and established medtech companies is accelerating research, commercialization, and global distribution. Environmental and ethical concerns around synthetic implants are also prompting a shift toward biodegradable and biologically derived alternatives. Collectively, these drivers are positioning biological implants as a critical component of next-generation medical care, where restoration of function is achieved not through replacement alone, but through true biological integration and regeneration.

SCOPE OF STUDY:

The report analyzes the Biological Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Biological Autografts, Biological Allografts, Biological Xenografts); Application (Cardiovascular Implants Application, Orthopedic Implants Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • AbbVie Inc.
  • Aroa Biosurgery
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical Inc.
  • Dentsply Sirona Inc.
  • Edwards Lifesciences Corporation
  • Globus Medical Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson (DePuy Synthes)
  • LivaNova PLC
  • Mathys Ltd Bettlach
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NuVasive Inc.
  • Smith & Nephew plc
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Biological Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases and Organ Failures Throws the Spotlight on Biological Implants
    • Advancements in Regenerative Medicine Spur Growth in Bioengineered and Cell-Based Implant Technologies
    • Here's How Aging Populations Are Expanding the Addressable Market for Cardiovascular and Orthopedic Implants
    • Increased Adoption of Xenografts and Allografts Strengthens the Business Case for Biologic Materials
    • Minimally Invasive Surgical Trends Drive Demand for Bio-Compatible and Resorbable Implant Solutions
    • Tissue Engineering Innovations Enhance Functional Integration and Longevity of Biological Implants
    • Global Growth in Organ Transplants and Reconstructive Surgeries Fuels Use of Soft Tissue Biological Scaffolds
    • Here's the Story: How 3D Bioprinting Is Creating Future Opportunities in Patient-Specific Biological Implants
    • Integration with Smart and Drug-Eluting Technologies Propels Next-Generation Implant Development
    • Rising Focus on Post-Surgical Healing and Biocompatibility Fuels Demand for Naturally Derived Implant Materials
    • Expansion of Biologic Mesh Use in Hernia and Pelvic Floor Repairs Drives Institutional Procurement
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biological Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biological Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Biological Autografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Biological Autografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Biological Autografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biological Allografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biological Allografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Biological Allografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Biological Xenografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Biological Xenografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Biological Xenografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiovascular Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cardiovascular Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Cardiovascular Implants Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Orthopedic Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Orthopedic Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Orthopedic Implants Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Biological Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Biological Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Biological Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Biological Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION